Big Tobacco Bets on Nicotine Pouches to Replace Declining Cigarette Sales

As global cigarette consumption continues its steady decline, tobacco giants are pivoting toward nicotine pouches to secure their financial future. Brands like Philip Morris International's Zyn and British American Tobacco's Velo are now positioned as high-margin growth engines, offering a regulatory landscape far less restrictive than traditional combustible products or vaping alternatives.

Editorial·August 18, 2026·reads: 2,109

Investors are closely watching whether these oral nicotine products can replicate their success in the United States and Scandinavia within new, untapped markets. While the transition remains complex, British American Tobacco reports climbing demand across Britain and Poland, alongside notable volume growth throughout Africa, Asia, and the Middle East. The industry is betting that these products will capture a significant share of the market, with revenue forecasts suggesting that pouches will eventually overtake the vaping sector by 2030.

Despite this optimism, the path to global dominance requires overcoming consumer habits in regions where oral nicotine lacks a historical foothold. Companies must also navigate the looming threat of stricter government oversight. For now, the combination of lucrative margins and expanding distribution footprints makes pouches the primary vehicle for sustaining profitability as the era of the cigarette wanes.